Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00411814
Status:
COMPLETED
Last Update Posted:
2012-03-19
First Post:
2006-12-14
Brief Title:
A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Dose-escalating Study of the Safety and Pharmacokinetics of GSK679586A in Healthy Volunteers and Mild Asthmatics
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a two part study Part I is designed to test single doses of GSK678586A in healthy volunteers Part II is designed to test repeat doses two doses of GSK679586A in patients with mild asthma Both parts are designed to investigate the safety tolerability and the way the body absorbs GSK679586A when given by intravenous infusion through a vein in your arm
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None